# CFAE/Spatiotemporal Dispersion Guided Ablation Versus PVI Guided Ablation in Persistent AF

> **NCT02696265** · NA · UNKNOWN · sponsor: **Diagram B.V.** · enrollment: 180 (estimated)

## Conditions studied

- Chronic Atrial Fibrillation

## Interventions

- **PROCEDURE:** CFAE guided ablation
- **PROCEDURE:** PVI guided ablation

## Key facts

- **NCT ID:** NCT02696265
- **Lead sponsor:** Diagram B.V.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-12
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2022-07-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02696265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02696265, "CFAE/Spatiotemporal Dispersion Guided Ablation Versus PVI Guided Ablation in Persistent AF". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02696265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*